These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

132 related items for PubMed ID: 11297037

  • 1. Activation of Gi-coupled receptors releases a tonic state of inhibited platelet aggregation.
    Maayani S, Schwarz T, Martinez R, Tagliente TM.
    Platelets; 2001 Mar; 12(2):94-8. PubMed ID: 11297037
    [Abstract] [Full Text] [Related]

  • 2. Activation of the alpha(2A)-adrenoceptor mediates deceleration of the deaggregation component of the response to ADP or 5-HT in human platelets in vitro.
    Maayani S, Schwarz T, Craddock-Royal B, Tagliente TM.
    Platelets; 2001 Sep; 12(6):359-75. PubMed ID: 11672475
    [Abstract] [Full Text] [Related]

  • 3. Costimulation of the Gi-coupled ADP receptor and the Gq-coupled TXA2 receptor is required for ERK2 activation in collagen-induced platelet aggregation.
    Roger S, Pawlowski M, Habib A, Jandrot-Perrus M, Rosa JP, Bryckaert M.
    FEBS Lett; 2004 Jan 02; 556(1-3):227-35. PubMed ID: 14706855
    [Abstract] [Full Text] [Related]

  • 4. Thrombopoietin complements G(i)- but not G(q)-dependent pathways for integrin {alpha}(IIb){beta}(3) activation and platelet aggregation.
    Campus F, Lova P, Bertoni A, Sinigaglia F, Balduini C, Torti M.
    J Biol Chem; 2005 Jul 01; 280(26):24386-95. PubMed ID: 15863506
    [Abstract] [Full Text] [Related]

  • 5. Agonist concentration-dependent differential responsivity of a human platelet purinergic receptor: pharmacological and kinetic studies of aggregation, deaggregation and shape change responses mediated by the purinergic P2Y1 receptor in vitro.
    Maayani S, Schwarz TE, Patel ND, Craddock-Royal BD, Tagliente TM.
    Platelets; 2003 Jul 01; 14(7-8):445-62. PubMed ID: 14713514
    [Abstract] [Full Text] [Related]

  • 6. Evidence for cross-talk between glycoprotein VI and Gi-coupled receptors during collagen-induced platelet aggregation.
    Nieswandt B, Bergmeier W, Eckly A, Schulte V, Ohlmann P, Cazenave JP, Zirngibl H, Offermanns S, Gachet C.
    Blood; 2001 Jun 15; 97(12):3829-35. PubMed ID: 11389023
    [Abstract] [Full Text] [Related]

  • 7. The P2Y12 antagonists, 2-methylthioadenosine 5'-monophosphate triethylammonium salt and cangrelor (ARC69931MX), can inhibit human platelet aggregation through a Gi-independent increase in cAMP levels.
    Srinivasan S, Mir F, Huang JS, Khasawneh FT, Lam SC, Le Breton GC.
    J Biol Chem; 2009 Jun 12; 284(24):16108-16117. PubMed ID: 19346255
    [Abstract] [Full Text] [Related]

  • 8. P2Y12 ADP receptor-dependent tyrosine phosphorylation of proteins of 27 and 31 kDa in thrombin-stimulated human platelets.
    Fälker K, Lange D, Presek P.
    Thromb Haemost; 2005 May 12; 93(5):880-8. PubMed ID: 15886804
    [Abstract] [Full Text] [Related]

  • 9. Coactivation of two different G protein-coupled receptors is essential for ADP-induced platelet aggregation.
    Jin J, Kunapuli SP.
    Proc Natl Acad Sci U S A; 1998 Jul 07; 95(14):8070-4. PubMed ID: 9653141
    [Abstract] [Full Text] [Related]

  • 10. (N)-methanocarba-2MeSADP (MRS2365) is a subtype-specific agonist that induces rapid desensitization of the P2Y1 receptor of human platelets.
    Bourdon DM, Mahanty SK, Jacobson KA, Boyer JL, Harden TK.
    J Thromb Haemost; 2006 Apr 07; 4(4):861-8. PubMed ID: 16634757
    [Abstract] [Full Text] [Related]

  • 11. Effect of clopidogrel administration to healthy volunteers on platelet phosphorylation events triggered by ADP.
    Contreres JO, Dupuy E, Job B, Habib A, Bryckaert M, Rosa JP, Simoneau G, Herbert JM, Savi P, Levy-Toledano S.
    Br J Haematol; 2003 Feb 07; 120(4):633-42. PubMed ID: 12588350
    [Abstract] [Full Text] [Related]

  • 12. ADP secretion and subsequent P2Y12 receptor signalling play a crucial role in thrombin-induced ERK2 activation in human platelets.
    Fälker K, Lange D, Presek P.
    Thromb Haemost; 2004 Jul 07; 92(1):114-23. PubMed ID: 15213852
    [Abstract] [Full Text] [Related]

  • 13. P2Y12, a new platelet ADP receptor, target of clopidogrel.
    Herbert JM, Savi P.
    Semin Vasc Med; 2003 May 07; 3(2):113-22. PubMed ID: 15199474
    [Abstract] [Full Text] [Related]

  • 14. On the mechanism of plasmin-induced platelet aggregation. Implications of the dual role of granule ADP.
    Ishii-Watabe A, Uchida E, Mizuguchi H, Hayakawa T.
    Biochem Pharmacol; 2000 Jun 01; 59(11):1345-55. PubMed ID: 10751543
    [Abstract] [Full Text] [Related]

  • 15. A Gi-dependent pathway is required for activation of the small GTPase Rap1B in human platelets.
    Lova P, Paganini S, Sinigaglia F, Balduini C, Torti M.
    J Biol Chem; 2002 Apr 05; 277(14):12009-15. PubMed ID: 11815620
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. The P2Y1 receptor, necessary but not sufficient to support full ADP-induced platelet aggregation, is not the target of the drug clopidogrel.
    Hechler B, Eckly A, Ohlmann P, Cazenave JP, Gachet C.
    Br J Haematol; 1998 Dec 05; 103(3):858-66. PubMed ID: 9858246
    [Abstract] [Full Text] [Related]

  • 19. Epinephrine-mediated protein kinase C and Rap1b activation requires the co-stimulation of Gz-, Gq-, and Gi-coupled receptors.
    Lova P, Guidetti GF, Canobbio I, Catricalà S, Balduini C, Torti M.
    Thromb Haemost; 2011 Mar 05; 105(3):479-86. PubMed ID: 21136013
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.